EUVIMEDEUVIMED entdecken
Crossref

Droplet pairing-merging enabled digital RPA-CRISPR/Cas12a (DIMERIC) assay for rapid and precise quantification of Hepatitis B Virus DNA

Dongyang Cai, Yifan Wang, Ziyi Zhang, Enqi Huang, Na Yang, Xiao Yang, Ting Zhang, Hongting Wen, Yu Wang, Zhenhua Chen, Hongkai Wu, Dayu Liu

Biosensors and Bioelectronics · 2025-05 · 276 · 117256

DOI: 10.1016/j.bios.2025.117256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2025-05. Verfasst von Dongyang Cai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, China…. Hauptthemen laut MEDLINE: Hepatitis B virus, CRISPR-Cas Systems, DNA, Viral, Nucleic Acid Amplification Techniques. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recombinase polymerase amplification (RPA)-CRISPR/Cas12a assays have demonstrated remarkable potential for point-of-care detection of pathogens in resource-limited settings. Nevertheless, these assays fall short in delivering direct quantitative results due to the incompatibility between the RPA and CRISPR/Cas12a systems. To overcome this limitation, we developed a droplet pairing-merging enabled digital RPA-CRISPR/Cas12a (DIMERIC) assay in this study. By leveraging a microfluidic chip with a calabash-shaped microwell array, large-volume RPA droplets and small-volume CRISPR/Cas12a droplets were sequentially and size-selectively trapped, generating one-to-one droplet pairs. This spatial separation of the droplets eliminates the inhibitory effects of the CRISPR/Cas12a chemistry on RPA. Upon the completion of RPA, the CRISPR/Cas12a system can be activated by merging the paired droplets. This temporal separation of the RPA and CRISPR/Cas reactions allows for the accumulation of sufficient amplicons to efficiently unleash the collateral cleavage activity. The DIMERIC assay offers rapid quantification of nucleic acids, with the entire procedure being accomplished within 20 min. This assay was employed for the quantitative detection of Hepatitis B virus DNA from batched clinical serum samples, demonstrating a good correlation with qPCR (R2 = 0.92033) and ddPCR (R2 = 0.97337) outcomes. Consequently, the developed DIMERIC assay provides a valuable tool for rapid and precise quantification of pathogenic nucleic acids.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B virusCRISPR-Cas SystemsDNA, ViralNucleic Acid Amplification TechniquesBiosensing TechniquesHepatitis BHumansLab-On-A-Chip DevicesRecombinasesEquipment Design

Stichwörter der Autor:innen

Digital assayDroplet pairing-mergingHepatitis B virus DNAMicrofluidicsRPA-CRISPR/Cas12a

Substanzen

DNA, ViralRecombinases

Autor:innen und Institutionen

  • Department of Laboratory Medicine, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, China; Guangdong Engineering Technology Research Center of Microfluidic Chi…
  • Department of Laboratory Medicine, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, China.
  • Department of Urology, The Second Affiliated Hospital, Dalian Medical University, Dalian, 116021, China.
  • Department of Laboratory Medicine, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, China; Micro-Nano Tech Center, Bioland Laboratory, Guangzhou, 510005, China.
  • Department of Chemistry, Hong Kong University of Science and Technology, Hong Kong, China.

Förderung

  • National Natural Science Foundation of China
  • Guangdong Provincial Natural Science Foundation

Zitieren

APA

Cai, D., Wang, Y., Zhang, Z., Huang, E., Yang, N., Yang, X., Zhang, T., Wen, H., Wang, Y., Chen, Z., Wu, H., & Liu, D. (2025). Droplet pairing-merging enabled digital RPA-CRISPR/Cas12a (DIMERIC) assay for rapid and precise quantification of Hepatitis B Virus DNA. Biosensors and Bioelectronics, 276, 117256. https://doi.org/10.1016/j.bios.2025.117256

Vancouver

Cai D, Wang Y, Zhang Z, Huang E, Yang N, Yang X, et al. Droplet pairing-merging enabled digital RPA-CRISPR/Cas12a (DIMERIC) assay for rapid and precise quantification of Hepatitis B Virus DNA. Biosensors and Bioelectronics. 2025;276:117256. doi:10.1016/j.bios.2025.117256

BibTeX
@article{Cai2025,
  author = {Cai, Dongyang and Wang, Yifan and Zhang, Ziyi and Huang, Enqi and Yang, Na and Yang, Xiao and Zhang, Ting and Wen, Hongting and Wang, Yu and Chen, Zhenhua and Wu, Hongkai and Liu, Dayu},
  title = {Droplet pairing-merging enabled digital RPA-CRISPR/Cas12a (DIMERIC) assay for rapid and precise quantification of Hepatitis B Virus DNA},
  journal = {Biosensors and Bioelectronics},
  year = {2025},
  volume = {276},
  pages = {117256},
  doi = {10.1016/j.bios.2025.117256}
}
Kostenlos starten →